Trial
NCT02087813
Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Stanford University
Collaborators
—
Condition
Neuromyelitis Optica
Intervention
Alpha1-antitrypsin
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-04-12